Therapeutic Application of rTMS in Atypical Parkinsonian Disorders. (23rd December 2021)

• Record Type: Journal Article
• Authors: Petsani, Chrysi; Aloizou, Athina-Maria; Siokas, Vasileios; Messinis, Lambros; Peristeri, Eleni; Bakirtzis, Christos; Nasios, Grigorios; Dardiotis, Efthimios
• Other Names: Lin Muh-Shi Academic Editor.
• Is Part Of: Behavioural neurology. Volume 2021(2021)
• Publication Date: 2021-12-23
• Subjects: Neuropsychology -- Periodicals; Neuropsychiatry -- Periodicals; Cognitive neuroscience -- Periodicals; 616.8005
• DOI: 10.1155/2021/3419907
• Languages: English
• ISSNs: 0953-4180

Abstract

Abstract : The terms atypical parkinsonian disorders (APDs) and Parkinson plus syndromes are mainly used to describe the four major entities of sporadic neuronal multisystem degeneration: progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and dementia with Lewy bodies (LBD). APDs are characterized by a variety of symptoms and a lack of disease modifying therapies; their treatment thus remains mainly symptomatic. Brain stimulation via repetitive transcranial magnetic stimulation (rTMS) is a safe and noninvasive intervention using a magnetic coil, and it is considered an alternative therapy in various neuropsychiatric pathologies. In this paper, we review the available studies that investigate the efficacy of rTMS in the treatment of these APDs and Parkinson plus syndromes. Τ he majority of the studies have shown beneficial effects on motor and nonmotor symptoms, but research is still at a preliminary phase, with large, double-blind studies lacking in the literature.